Efficacy and Safety of Ergoferon for COVID-19 Prevention During Vaccination Against SARS-CoV-2

NCT05069649 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1057

Enrollment

INDUSTRY

Sponsor class

Conditions

Immunization Against COVID-19

Interventions

DRUG: Ergoferon
DRUG: Placebo

Sponsor

Materia Medica Holding